nodes	percent_of_prediction	percent_of_DWPC	metapath
Mepivacaine—SCN8A—nerve—acquired immunodeficiency syndrome	0.0312	0.111	CbGeAlD
Mepivacaine—SCN10A—nerve—acquired immunodeficiency syndrome	0.0209	0.0743	CbGeAlD
Mepivacaine—SCN8A—spinal cord—acquired immunodeficiency syndrome	0.00832	0.0297	CbGeAlD
Mepivacaine—SCN9A—spinal cord—acquired immunodeficiency syndrome	0.00732	0.0261	CbGeAlD
Mepivacaine—SCN8A—nervous system—acquired immunodeficiency syndrome	0.00701	0.025	CbGeAlD
Mepivacaine—SCN8A—central nervous system—acquired immunodeficiency syndrome	0.00675	0.0241	CbGeAlD
Mepivacaine—SCN9A—lung—acquired immunodeficiency syndrome	0.00666	0.0237	CbGeAlD
Mepivacaine—SCN1A—spinal cord—acquired immunodeficiency syndrome	0.00629	0.0224	CbGeAlD
Mepivacaine—SCN10A—lymphoid tissue—acquired immunodeficiency syndrome	0.00614	0.0219	CbGeAlD
Mepivacaine—SCN2A—blood—acquired immunodeficiency syndrome	0.006	0.0214	CbGeAlD
Mepivacaine—SCN10A—blood—acquired immunodeficiency syndrome	0.00578	0.0206	CbGeAlD
Mepivacaine—SCN2A—spinal cord—acquired immunodeficiency syndrome	0.00578	0.0206	CbGeAlD
Mepivacaine—SCN1A—lung—acquired immunodeficiency syndrome	0.00573	0.0204	CbGeAlD
Mepivacaine—SCN10A—spinal cord—acquired immunodeficiency syndrome	0.00557	0.0198	CbGeAlD
Mepivacaine—SCN2A—vagina—acquired immunodeficiency syndrome	0.00556	0.0198	CbGeAlD
Mepivacaine—SCN5A—digestive system—acquired immunodeficiency syndrome	0.00551	0.0196	CbGeAlD
Mepivacaine—SCN4A—nervous system—acquired immunodeficiency syndrome	0.0055	0.0196	CbGeAlD
Mepivacaine—SCN8A—brain—acquired immunodeficiency syndrome	0.00536	0.0191	CbGeAlD
Mepivacaine—SCN1A—nervous system—acquired immunodeficiency syndrome	0.0053	0.0189	CbGeAlD
Mepivacaine—SCN4A—central nervous system—acquired immunodeficiency syndrome	0.00529	0.0189	CbGeAlD
Mepivacaine—SCN3A—blood—acquired immunodeficiency syndrome	0.00527	0.0188	CbGeAlD
Mepivacaine—SCN5A—blood—acquired immunodeficiency syndrome	0.00525	0.0187	CbGeAlD
Mepivacaine—SCN1A—central nervous system—acquired immunodeficiency syndrome	0.00511	0.0182	CbGeAlD
Mepivacaine—SCN3A—bone marrow—acquired immunodeficiency syndrome	0.0051	0.0182	CbGeAlD
Mepivacaine—SCN3A—spinal cord—acquired immunodeficiency syndrome	0.00508	0.0181	CbGeAlD
Mepivacaine—SCN10A—lung—acquired immunodeficiency syndrome	0.00507	0.0181	CbGeAlD
Mepivacaine—SCN3A—vagina—acquired immunodeficiency syndrome	0.00488	0.0174	CbGeAlD
Mepivacaine—SCN5A—vagina—acquired immunodeficiency syndrome	0.00487	0.0174	CbGeAlD
Mepivacaine—SCN2A—nervous system—acquired immunodeficiency syndrome	0.00487	0.0173	CbGeAlD
Mepivacaine—SCN9A—brain—acquired immunodeficiency syndrome	0.00471	0.0168	CbGeAlD
Mepivacaine—SCN10A—nervous system—acquired immunodeficiency syndrome	0.00469	0.0167	CbGeAlD
Mepivacaine—SCN2A—central nervous system—acquired immunodeficiency syndrome	0.00469	0.0167	CbGeAlD
Mepivacaine—SCN3A—lung—acquired immunodeficiency syndrome	0.00462	0.0165	CbGeAlD
Mepivacaine—SCN9A—lymph node—acquired immunodeficiency syndrome	0.00455	0.0162	CbGeAlD
Mepivacaine—SCN10A—central nervous system—acquired immunodeficiency syndrome	0.00452	0.0161	CbGeAlD
Mepivacaine—SCN3A—nervous system—acquired immunodeficiency syndrome	0.00428	0.0152	CbGeAlD
Mepivacaine—SCN5A—nervous system—acquired immunodeficiency syndrome	0.00427	0.0152	CbGeAlD
Mepivacaine—SCN4A—brain—acquired immunodeficiency syndrome	0.0042	0.015	CbGeAlD
Mepivacaine—SCN3A—central nervous system—acquired immunodeficiency syndrome	0.00412	0.0147	CbGeAlD
Mepivacaine—SCN5A—central nervous system—acquired immunodeficiency syndrome	0.00411	0.0146	CbGeAlD
Mepivacaine—SCN1A—brain—acquired immunodeficiency syndrome	0.00405	0.0144	CbGeAlD
Mepivacaine—SCN2A—brain—acquired immunodeficiency syndrome	0.00372	0.0133	CbGeAlD
Mepivacaine—SCN10A—brain—acquired immunodeficiency syndrome	0.00359	0.0128	CbGeAlD
Mepivacaine—SCN10A—lymph node—acquired immunodeficiency syndrome	0.00347	0.0123	CbGeAlD
Mepivacaine—SCN3A—brain—acquired immunodeficiency syndrome	0.00327	0.0116	CbGeAlD
Mepivacaine—SCN5A—brain—acquired immunodeficiency syndrome	0.00326	0.0116	CbGeAlD
Mepivacaine—SCN3A—lymph node—acquired immunodeficiency syndrome	0.00316	0.0113	CbGeAlD
Mepivacaine—Back pain—Zidovudine—acquired immunodeficiency syndrome	0.00275	0.00382	CcSEcCtD
Mepivacaine—Anxiety—Abacavir—acquired immunodeficiency syndrome	0.00273	0.00379	CcSEcCtD
Mepivacaine—Chills—Indinavir—acquired immunodeficiency syndrome	0.00272	0.00378	CcSEcCtD
Mepivacaine—Sweating—Ritonavir—acquired immunodeficiency syndrome	0.00271	0.00376	CcSEcCtD
Mepivacaine—Oedema—Nelfinavir—acquired immunodeficiency syndrome	0.00267	0.00372	CcSEcCtD
Mepivacaine—Tinnitus—Efavirenz—acquired immunodeficiency syndrome	0.00267	0.00371	CcSEcCtD
Mepivacaine—Tremor—Zidovudine—acquired immunodeficiency syndrome	0.00266	0.0037	CcSEcCtD
Mepivacaine—Anaphylactic shock—Abacavir—acquired immunodeficiency syndrome	0.00263	0.00365	CcSEcCtD
Mepivacaine—Oedema—Abacavir—acquired immunodeficiency syndrome	0.00263	0.00365	CcSEcCtD
Mepivacaine—Angioedema—Zidovudine—acquired immunodeficiency syndrome	0.00259	0.00361	CcSEcCtD
Mepivacaine—Tension—Indinavir—acquired immunodeficiency syndrome	0.00259	0.0036	CcSEcCtD
Mepivacaine—Hyperhidrosis—Nelfinavir—acquired immunodeficiency syndrome	0.00258	0.00359	CcSEcCtD
Mepivacaine—Hyperhidrosis—Stavudine—acquired immunodeficiency syndrome	0.00258	0.00358	CcSEcCtD
Mepivacaine—Nervousness—Indinavir—acquired immunodeficiency syndrome	0.00256	0.00356	CcSEcCtD
Mepivacaine—Tinnitus—Delavirdine—acquired immunodeficiency syndrome	0.00256	0.00355	CcSEcCtD
Mepivacaine—Back pain—Indinavir—acquired immunodeficiency syndrome	0.00255	0.00355	CcSEcCtD
Mepivacaine—Syncope—Zidovudine—acquired immunodeficiency syndrome	0.00254	0.00354	CcSEcCtD
Mepivacaine—Loss of consciousness—Zidovudine—acquired immunodeficiency syndrome	0.00249	0.00347	CcSEcCtD
Mepivacaine—Erythema—Efavirenz—acquired immunodeficiency syndrome	0.00249	0.00347	CcSEcCtD
Mepivacaine—Vision blurred—Indinavir—acquired immunodeficiency syndrome	0.00249	0.00346	CcSEcCtD
Mepivacaine—Sweating—Lamivudine—acquired immunodeficiency syndrome	0.00249	0.00346	CcSEcCtD
Mepivacaine—Paraesthesia—Nevirapine—acquired immunodeficiency syndrome	0.00248	0.00345	CcSEcCtD
Mepivacaine—Tremor—Indinavir—acquired immunodeficiency syndrome	0.00247	0.00344	CcSEcCtD
Mepivacaine—Chills—Delavirdine—acquired immunodeficiency syndrome	0.00246	0.00342	CcSEcCtD
Mepivacaine—Convulsion—Zidovudine—acquired immunodeficiency syndrome	0.00246	0.00342	CcSEcCtD
Mepivacaine—Somnolence—Nevirapine—acquired immunodeficiency syndrome	0.00245	0.00341	CcSEcCtD
Mepivacaine—Hypotension—Abacavir—acquired immunodeficiency syndrome	0.00245	0.00341	CcSEcCtD
Mepivacaine—Tension—Efavirenz—acquired immunodeficiency syndrome	0.00245	0.0034	CcSEcCtD
Mepivacaine—Body temperature increased—Didanosine—acquired immunodeficiency syndrome	0.00243	0.00337	CcSEcCtD
Mepivacaine—Agitation—Indinavir—acquired immunodeficiency syndrome	0.00243	0.00337	CcSEcCtD
Mepivacaine—Nervousness—Efavirenz—acquired immunodeficiency syndrome	0.00242	0.00337	CcSEcCtD
Mepivacaine—Asthenia—Amprenavir—acquired immunodeficiency syndrome	0.00242	0.00336	CcSEcCtD
Mepivacaine—Back pain—Efavirenz—acquired immunodeficiency syndrome	0.00241	0.00335	CcSEcCtD
Mepivacaine—Angioedema—Indinavir—acquired immunodeficiency syndrome	0.00241	0.00335	CcSEcCtD
Mepivacaine—Anxiety—Zidovudine—acquired immunodeficiency syndrome	0.00241	0.00335	CcSEcCtD
Mepivacaine—Paraesthesia—Nelfinavir—acquired immunodeficiency syndrome	0.0024	0.00334	CcSEcCtD
Mepivacaine—Paraesthesia—Stavudine—acquired immunodeficiency syndrome	0.00239	0.00333	CcSEcCtD
Mepivacaine—Erythema—Delavirdine—acquired immunodeficiency syndrome	0.00239	0.00332	CcSEcCtD
Mepivacaine—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.00238	0.00331	CcSEcCtD
Mepivacaine—Somnolence—Nelfinavir—acquired immunodeficiency syndrome	0.00238	0.0033	CcSEcCtD
Mepivacaine—Somnolence—Stavudine—acquired immunodeficiency syndrome	0.00237	0.00329	CcSEcCtD
Mepivacaine—Syncope—Indinavir—acquired immunodeficiency syndrome	0.00237	0.00329	CcSEcCtD
Mepivacaine—Tinnitus—Ritonavir—acquired immunodeficiency syndrome	0.00236	0.00329	CcSEcCtD
Mepivacaine—Paraesthesia—Abacavir—acquired immunodeficiency syndrome	0.00236	0.00328	CcSEcCtD
Mepivacaine—Vision blurred—Efavirenz—acquired immunodeficiency syndrome	0.00235	0.00327	CcSEcCtD
Mepivacaine—Tension—Delavirdine—acquired immunodeficiency syndrome	0.00234	0.00325	CcSEcCtD
Mepivacaine—Tremor—Efavirenz—acquired immunodeficiency syndrome	0.00234	0.00325	CcSEcCtD
Mepivacaine—Loss of consciousness—Indinavir—acquired immunodeficiency syndrome	0.00232	0.00322	CcSEcCtD
Mepivacaine—Nervousness—Delavirdine—acquired immunodeficiency syndrome	0.00232	0.00322	CcSEcCtD
Mepivacaine—Oedema—Zidovudine—acquired immunodeficiency syndrome	0.00232	0.00322	CcSEcCtD
Mepivacaine—Anaphylactic shock—Zidovudine—acquired immunodeficiency syndrome	0.00232	0.00322	CcSEcCtD
Mepivacaine—Back pain—Delavirdine—acquired immunodeficiency syndrome	0.00231	0.00321	CcSEcCtD
Mepivacaine—Agitation—Efavirenz—acquired immunodeficiency syndrome	0.00229	0.00319	CcSEcCtD
Mepivacaine—Shock—Zidovudine—acquired immunodeficiency syndrome	0.00228	0.00317	CcSEcCtD
Mepivacaine—Angioedema—Efavirenz—acquired immunodeficiency syndrome	0.00228	0.00317	CcSEcCtD
Mepivacaine—Tinnitus—Saquinavir—acquired immunodeficiency syndrome	0.00227	0.00316	CcSEcCtD
Mepivacaine—Chills—Ritonavir—acquired immunodeficiency syndrome	0.00227	0.00316	CcSEcCtD
Mepivacaine—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.00226	0.00314	CcSEcCtD
Mepivacaine—Vision blurred—Delavirdine—acquired immunodeficiency syndrome	0.00225	0.00313	CcSEcCtD
Mepivacaine—Anxiety—Indinavir—acquired immunodeficiency syndrome	0.00224	0.00311	CcSEcCtD
Mepivacaine—Hyperhidrosis—Zidovudine—acquired immunodeficiency syndrome	0.00224	0.00311	CcSEcCtD
Mepivacaine—Syncope—Efavirenz—acquired immunodeficiency syndrome	0.00224	0.00311	CcSEcCtD
Mepivacaine—Tremor—Delavirdine—acquired immunodeficiency syndrome	0.00224	0.00311	CcSEcCtD
Mepivacaine—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.0022	0.00306	CcSEcCtD
Mepivacaine—Agitation—Delavirdine—acquired immunodeficiency syndrome	0.00219	0.00305	CcSEcCtD
Mepivacaine—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.00219	0.00305	CcSEcCtD
Mepivacaine—Loss of consciousness—Efavirenz—acquired immunodeficiency syndrome	0.00219	0.00305	CcSEcCtD
Mepivacaine—Chills—Saquinavir—acquired immunodeficiency syndrome	0.00219	0.00304	CcSEcCtD
Mepivacaine—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	0.00218	0.00303	CcSEcCtD
Mepivacaine—Angioedema—Delavirdine—acquired immunodeficiency syndrome	0.00218	0.00303	CcSEcCtD
Mepivacaine—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.00217	0.00302	CcSEcCtD
Mepivacaine—Tension—Ritonavir—acquired immunodeficiency syndrome	0.00217	0.00301	CcSEcCtD
Mepivacaine—Convulsion—Efavirenz—acquired immunodeficiency syndrome	0.00216	0.003	CcSEcCtD
Mepivacaine—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.00215	0.00299	CcSEcCtD
Mepivacaine—Oedema—Indinavir—acquired immunodeficiency syndrome	0.00215	0.00299	CcSEcCtD
Mepivacaine—Hypertension—Efavirenz—acquired immunodeficiency syndrome	0.00215	0.00299	CcSEcCtD
Mepivacaine—Nervousness—Ritonavir—acquired immunodeficiency syndrome	0.00214	0.00298	CcSEcCtD
Mepivacaine—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.00214	0.00298	CcSEcCtD
Mepivacaine—Syncope—Delavirdine—acquired immunodeficiency syndrome	0.00214	0.00297	CcSEcCtD
Mepivacaine—Back pain—Ritonavir—acquired immunodeficiency syndrome	0.00213	0.00297	CcSEcCtD
Mepivacaine—Erythema—Saquinavir—acquired immunodeficiency syndrome	0.00212	0.00295	CcSEcCtD
Mepivacaine—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.00212	0.00295	CcSEcCtD
Mepivacaine—Shock—Indinavir—acquired immunodeficiency syndrome	0.00212	0.00295	CcSEcCtD
Mepivacaine—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.00212	0.00294	CcSEcCtD
Mepivacaine—Anxiety—Efavirenz—acquired immunodeficiency syndrome	0.00212	0.00294	CcSEcCtD
Mepivacaine—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.00211	0.00294	CcSEcCtD
Mepivacaine—Headache—Amprenavir—acquired immunodeficiency syndrome	0.00211	0.00293	CcSEcCtD
Mepivacaine—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.00211	0.00293	CcSEcCtD
Mepivacaine—Loss of consciousness—Delavirdine—acquired immunodeficiency syndrome	0.0021	0.00292	CcSEcCtD
Mepivacaine—Chills—Lamivudine—acquired immunodeficiency syndrome	0.00209	0.0029	CcSEcCtD
Mepivacaine—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.00209	0.0029	CcSEcCtD
Mepivacaine—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.00208	0.00289	CcSEcCtD
Mepivacaine—Paraesthesia—Zidovudine—acquired immunodeficiency syndrome	0.00208	0.00289	CcSEcCtD
Mepivacaine—Vision blurred—Ritonavir—acquired immunodeficiency syndrome	0.00208	0.00289	CcSEcCtD
Mepivacaine—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.00208	0.00289	CcSEcCtD
Mepivacaine—Tremor—Ritonavir—acquired immunodeficiency syndrome	0.00207	0.00287	CcSEcCtD
Mepivacaine—Hypertension—Delavirdine—acquired immunodeficiency syndrome	0.00206	0.00286	CcSEcCtD
Mepivacaine—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.00206	0.00286	CcSEcCtD
Mepivacaine—Back pain—Saquinavir—acquired immunodeficiency syndrome	0.00205	0.00286	CcSEcCtD
Mepivacaine—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.00203	0.00283	CcSEcCtD
Mepivacaine—Agitation—Ritonavir—acquired immunodeficiency syndrome	0.00203	0.00282	CcSEcCtD
Mepivacaine—Erythema—Lamivudine—acquired immunodeficiency syndrome	0.00203	0.00282	CcSEcCtD
Mepivacaine—Anxiety—Delavirdine—acquired immunodeficiency syndrome	0.00202	0.00281	CcSEcCtD
Mepivacaine—Shock—Efavirenz—acquired immunodeficiency syndrome	0.002	0.00278	CcSEcCtD
Mepivacaine—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.002	0.00278	CcSEcCtD
Mepivacaine—Tremor—Saquinavir—acquired immunodeficiency syndrome	0.00199	0.00277	CcSEcCtD
Mepivacaine—Tension—Lamivudine—acquired immunodeficiency syndrome	0.00199	0.00276	CcSEcCtD
Mepivacaine—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.00199	0.00276	CcSEcCtD
Mepivacaine—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.00198	0.00275	CcSEcCtD
Mepivacaine—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.00198	0.00275	CcSEcCtD
Mepivacaine—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.00197	0.00274	CcSEcCtD
Mepivacaine—Nervousness—Lamivudine—acquired immunodeficiency syndrome	0.00197	0.00274	CcSEcCtD
Mepivacaine—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.00197	0.00274	CcSEcCtD
Mepivacaine—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.00196	0.00273	CcSEcCtD
Mepivacaine—Back pain—Lamivudine—acquired immunodeficiency syndrome	0.00196	0.00272	CcSEcCtD
Mepivacaine—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.00195	0.00271	CcSEcCtD
Mepivacaine—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.00195	0.00271	CcSEcCtD
Mepivacaine—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.00195	0.00271	CcSEcCtD
Mepivacaine—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.00195	0.00271	CcSEcCtD
Mepivacaine—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.00194	0.0027	CcSEcCtD
Mepivacaine—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.00193	0.00269	CcSEcCtD
Mepivacaine—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.00193	0.00269	CcSEcCtD
Mepivacaine—Headache—Didanosine—acquired immunodeficiency syndrome	0.00192	0.00267	CcSEcCtD
Mepivacaine—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.00192	0.00267	CcSEcCtD
Mepivacaine—Shock—Delavirdine—acquired immunodeficiency syndrome	0.00192	0.00266	CcSEcCtD
Mepivacaine—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.00191	0.00266	CcSEcCtD
Mepivacaine—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.00191	0.00266	CcSEcCtD
Mepivacaine—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.00191	0.00266	CcSEcCtD
Mepivacaine—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.0019	0.00265	CcSEcCtD
Mepivacaine—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.0019	0.00265	CcSEcCtD
Mepivacaine—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.0019	0.00264	CcSEcCtD
Mepivacaine—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.0019	0.00264	CcSEcCtD
Mepivacaine—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.00189	0.00263	CcSEcCtD
Mepivacaine—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.00189	0.00262	CcSEcCtD
Mepivacaine—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.00188	0.00262	CcSEcCtD
Mepivacaine—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.00188	0.00262	CcSEcCtD
Mepivacaine—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.00187	0.0026	CcSEcCtD
Mepivacaine—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.00187	0.00259	CcSEcCtD
Mepivacaine—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.00186	0.00258	CcSEcCtD
Mepivacaine—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.00185	0.00257	CcSEcCtD
Mepivacaine—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.00184	0.00256	CcSEcCtD
Mepivacaine—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.00184	0.00256	CcSEcCtD
Mepivacaine—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.00183	0.00255	CcSEcCtD
Mepivacaine—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.00183	0.00255	CcSEcCtD
Mepivacaine—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.00183	0.00254	CcSEcCtD
Mepivacaine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00182	0.00253	CcSEcCtD
Mepivacaine—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.00182	0.00253	CcSEcCtD
Mepivacaine—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.00182	0.00253	CcSEcCtD
Mepivacaine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.00181	0.00252	CcSEcCtD
Mepivacaine—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.0018	0.0025	CcSEcCtD
Mepivacaine—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.0018	0.0025	CcSEcCtD
Mepivacaine—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.00178	0.00248	CcSEcCtD
Mepivacaine—Shock—Ritonavir—acquired immunodeficiency syndrome	0.00177	0.00246	CcSEcCtD
Mepivacaine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.00177	0.00246	CcSEcCtD
Mepivacaine—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.00176	0.00245	CcSEcCtD
Mepivacaine—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.00176	0.00244	CcSEcCtD
Mepivacaine—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.00176	0.00244	CcSEcCtD
Mepivacaine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.00175	0.00244	CcSEcCtD
Mepivacaine—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.00175	0.00243	CcSEcCtD
Mepivacaine—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.00174	0.00242	CcSEcCtD
Mepivacaine—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.00174	0.00241	CcSEcCtD
Mepivacaine—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.00173	0.00241	CcSEcCtD
Mepivacaine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.00173	0.00241	CcSEcCtD
Mepivacaine—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00173	0.0024	CcSEcCtD
Mepivacaine—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.00172	0.00239	CcSEcCtD
Mepivacaine—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.00171	0.00238	CcSEcCtD
Mepivacaine—Shock—Saquinavir—acquired immunodeficiency syndrome	0.00171	0.00237	CcSEcCtD
Mepivacaine—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.0017	0.00237	CcSEcCtD
Mepivacaine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.0017	0.00236	CcSEcCtD
Mepivacaine—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.00169	0.00236	CcSEcCtD
Mepivacaine—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.00168	0.00234	CcSEcCtD
Mepivacaine—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.00168	0.00233	CcSEcCtD
Mepivacaine—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.00167	0.00233	CcSEcCtD
Mepivacaine—Headache—Stavudine—acquired immunodeficiency syndrome	0.00167	0.00232	CcSEcCtD
Mepivacaine—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.00167	0.00232	CcSEcCtD
Mepivacaine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.00166	0.00231	CcSEcCtD
Mepivacaine—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.00165	0.0023	CcSEcCtD
Mepivacaine—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.00165	0.0023	CcSEcCtD
Mepivacaine—Headache—Abacavir—acquired immunodeficiency syndrome	0.00164	0.00229	CcSEcCtD
Mepivacaine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.00164	0.00228	CcSEcCtD
Mepivacaine—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.00164	0.00228	CcSEcCtD
Mepivacaine—Shock—Lamivudine—acquired immunodeficiency syndrome	0.00163	0.00226	CcSEcCtD
Mepivacaine—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.00162	0.00225	CcSEcCtD
Mepivacaine—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.00162	0.00225	CcSEcCtD
Mepivacaine—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.00162	0.00225	CcSEcCtD
Mepivacaine—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.00161	0.00224	CcSEcCtD
Mepivacaine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.0016	0.00223	CcSEcCtD
Mepivacaine—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.0016	0.00222	CcSEcCtD
Mepivacaine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00159	0.00221	CcSEcCtD
Mepivacaine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.00159	0.00221	CcSEcCtD
Mepivacaine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.00158	0.0022	CcSEcCtD
Mepivacaine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.00156	0.00217	CcSEcCtD
Mepivacaine—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.00156	0.00216	CcSEcCtD
Mepivacaine—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.00155	0.00215	CcSEcCtD
Mepivacaine—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.00155	0.00215	CcSEcCtD
Mepivacaine—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.00154	0.00215	CcSEcCtD
Mepivacaine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.00154	0.00214	CcSEcCtD
Mepivacaine—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.00154	0.00214	CcSEcCtD
Mepivacaine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.00153	0.00213	CcSEcCtD
Mepivacaine—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.00152	0.00212	CcSEcCtD
Mepivacaine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.0015	0.00208	CcSEcCtD
Mepivacaine—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.00148	0.00206	CcSEcCtD
Mepivacaine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.00147	0.00205	CcSEcCtD
Mepivacaine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.00147	0.00204	CcSEcCtD
Mepivacaine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.00146	0.00203	CcSEcCtD
Mepivacaine—Headache—Zidovudine—acquired immunodeficiency syndrome	0.00145	0.00202	CcSEcCtD
Mepivacaine—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.00144	0.002	CcSEcCtD
Mepivacaine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.00143	0.00199	CcSEcCtD
Mepivacaine—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.00143	0.00199	CcSEcCtD
Mepivacaine—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.00142	0.00198	CcSEcCtD
Mepivacaine—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.00142	0.00198	CcSEcCtD
Mepivacaine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.0014	0.00194	CcSEcCtD
Mepivacaine—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.00138	0.00192	CcSEcCtD
Mepivacaine—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.00138	0.00191	CcSEcCtD
Mepivacaine—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.00138	0.00191	CcSEcCtD
Mepivacaine—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.00137	0.0019	CcSEcCtD
Mepivacaine—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.00137	0.0019	CcSEcCtD
Mepivacaine—Headache—Indinavir—acquired immunodeficiency syndrome	0.00135	0.00188	CcSEcCtD
Mepivacaine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.00135	0.00187	CcSEcCtD
Mepivacaine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.00133	0.00184	CcSEcCtD
Mepivacaine—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.00131	0.00183	CcSEcCtD
Mepivacaine—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.00131	0.00182	CcSEcCtD
Mepivacaine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.00129	0.0018	CcSEcCtD
Mepivacaine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.00129	0.0018	CcSEcCtD
Mepivacaine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.00129	0.00179	CcSEcCtD
Mepivacaine—Nausea—Indinavir—acquired immunodeficiency syndrome	0.00128	0.00178	CcSEcCtD
Mepivacaine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.00128	0.00178	CcSEcCtD
Mepivacaine—Headache—Efavirenz—acquired immunodeficiency syndrome	0.00127	0.00177	CcSEcCtD
Mepivacaine—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.00127	0.00177	CcSEcCtD
Mepivacaine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.00124	0.00173	CcSEcCtD
Mepivacaine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.00124	0.00172	CcSEcCtD
Mepivacaine—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.00123	0.0017	CcSEcCtD
Mepivacaine—Headache—Delavirdine—acquired immunodeficiency syndrome	0.00122	0.0017	CcSEcCtD
Mepivacaine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.00122	0.00169	CcSEcCtD
Mepivacaine—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.00121	0.00168	CcSEcCtD
Mepivacaine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.00119	0.00166	CcSEcCtD
Mepivacaine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.00119	0.00165	CcSEcCtD
Mepivacaine—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.00117	0.00163	CcSEcCtD
Mepivacaine—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.00116	0.00161	CcSEcCtD
Mepivacaine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.00115	0.00159	CcSEcCtD
Mepivacaine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.00114	0.00159	CcSEcCtD
Mepivacaine—Headache—Ritonavir—acquired immunodeficiency syndrome	0.00113	0.00157	CcSEcCtD
Mepivacaine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.0011	0.00153	CcSEcCtD
Mepivacaine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.00109	0.00152	CcSEcCtD
Mepivacaine—Headache—Saquinavir—acquired immunodeficiency syndrome	0.00109	0.00151	CcSEcCtD
Mepivacaine—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.00107	0.00149	CcSEcCtD
Mepivacaine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.00105	0.00146	CcSEcCtD
Mepivacaine—Headache—Lamivudine—acquired immunodeficiency syndrome	0.00104	0.00144	CcSEcCtD
Mepivacaine—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.00103	0.00143	CcSEcCtD
Mepivacaine—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000982	0.00137	CcSEcCtD
